News|Articles|October 11, 2024
Antibody peptide mapping using the new Agilent ExD cell
Author(s)Agilent Technologies, Inc.
Enhanced antibody analysis using electron capture dissociation (ECD) allows for precise glycan localization in low-abundance glycopeptides. This study compares the fragmentation of trastuzumab tryptic digests using ECD and collision-induced dissociation (CID). While CID generates abundant glycan HexNAc ions at 204 m/z, ECD preserves the labile glycan group, enabling accurate site localization.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
Hyphenated Chromatography Methods: Successes and Remaining Challenges
4
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
5